Researchers are excited about this new drug, a novel dual agonist showing promising outcomes in clinical trials for size reduction . It acts by targeting several pathways : GLP-1 and GIP, that , when https://harmonywzch350523.widblog.com/95654792/the-new-hope-for-weight-reduction